TherapeuticsMD Announces Submission of New Drug Application for TX-001HR

8 years ago

by David Miller

970 Views

Written by David Miller

BOCA RATON, Fla.–(BUSINESS WIRE)–Dec. 28, 2017– TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative women’s healthcare company, announced today that it has submitted the New Drug Application (NDA) for TX-001HR, the company’s investigational…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!